// Publications

// Select publication year: 2008
78. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell 2008, 7:491-497. (IF 8)

Koppelstaetter C, Schratzberger G, Perco P, Hofer J, Mark W, Ollinger R, Oberbauer R, Schwarz C, Mitterbauer C, Kainz A, Karkoszka H, Wiecek A, Mayer B, Mayer G.

77. Biocompatibility of Hemodialysis Membranes Determined by Differential Gene Expression Analysis of Human Leukocytes: A randomized Cross-over Study. Eur J Clin Invest 2008, 38: 918–924 (IF 4.4)

Wilflingseder J, Perco P, Kainz A, Mayer B, Oberbauer R.

76. Short-term effects of high dose zoledronic acid treatment on bone mineralization density distribution (BMDD) after orthotopic liver transplantation. Calcif Tiss Int 2008, 83:167-175. (IF 3.3)

Misof BM, Bodingbauer M, Roschger P, Wekerle T, Pakrah B, Haas M, Kainz A, Oberbauer R, Mühlbacher F, Klaushofer K.

75. Can we really predict the change in serum sodium levels? – An analysis of currently proposed formulae in hypernatremic patients. Nephrol Dial Transplant 2008, 23:3501-3508. (IF 4.8)

Lindner G, Schwarz C, Kneidinger N, Kramer L, Oberbauer R, Druml W.

74. Statin use is associated with prolonged survival of renal transplant recipients. JASN 2008,19:2211-2218. (IF 10.3)

Wiesbauer F, Heinze G, Mitterbauer C, Harnoncourt F, Hörl WH, Oberbauer R.

73. Elevated Uric Acid Increases the Risk for Kidney Disease. JASN 2008, 19:2407-13. (IF 10.3)

Obermayr R, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R.

72. A single nucleotide polymorphism at chromosome 2q21.3 (LCT 13910C>T) associates with clinical outcome after allogeneic hematopoetic stem cell transplantation. Blood 2008, 112:2156-2159. (IF 21)

Hauser H, Zach O, Krieger O, Kasparu H, Koenig J, Girschikofsky M, Oberbauer R, Lutz D.

71. Predictors of new-onset decline in kidney function in a general middle-European population. Nephrol Dial Transplant 2008, 23:1265-1273. (IF 4.8)

Obermayr RP, Temml C, Knechtelsdorfer M, Gutjahr G, Kletzmayr J, Heiss S, Ponholzer A, Madersbacher S, Oberauer R, Klauser-Braun R.

70. ACE-Inhibitor or AT2-Antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations. Nephrol Dial Transplant 2008, 23:1742-1746. (IF 4.8)

Mitterbauer C, Heinze G, Kainz A, Kramar R, Hörl WH, Oberbauer R.

SCIENTIFIC COLLABORATIONS